<table id="id_2fd30f2a-b73b-4c29-88ab-1f1bf6ac8a19" width="0.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col></col>
<col></col>
<thead>
<tr id="id_8697dc52-347d-419c-a491-6b21f78d2f58" stylecode="Botrule">
<td align="center" colspan="2" valign="top">
<content stylecode="bold">Table 4 Drugs Tested in <content stylecode="italics">In Vitro</content> Binding or <content stylecode="italics">In Vivo</content> Drug Interaction Testing or With Post-Marketing Reports</content>
</td>
</tr>
</thead>
<tfoot id="id_fc992f44-1d3e-4d69-ab7b-1120076c13f1">
<tr>
<td align="left" colspan="2" valign="top">
<sup>a</sup> Should be administered at least 4 hours prior to WELCHOL</td>
</tr>
<tr>
<td align="left" colspan="2" valign="top">
<sup>b</sup> No significant alteration of warfarin drug levels with warfarin and WELCHOL coadministration in an <content stylecode="italics">in vivo</content> study which did not evaluate warfarin pharmacodynamics (INR). <content stylecode="italics">[See Post-marketing Experience <linkhtml href="#i4i_section_id_15aaef75-7c0d-4c23-8ebb-b0b3f235e0c9">(6.2)</linkhtml>]</content>
</td>
</tr>
<tr>
<td align="left" colspan="2" valign="top">
<sup>c</sup> Cyclosporine levels should be monitored and, based on theoretical grounds, cyclosporine should be administered at least 4 hours prior to WELCHOL. </td>
</tr>
</tfoot>
<tbody>
<tr id="id_e7a6978e-70b1-4f69-b0e2-464a799720f2" stylecode="Toprule">
<td align="left" valign="top">Drugs with a known interaction with colesevelam </td>
<td align="left" valign="top">Cyclosporine<sup>c</sup>, glyburide<sup>a</sup>, levothyroxine<sup>a</sup>, and oral contraceptives containing ethinyl estradiol and norethindrone<sup>a</sup>
</td>
</tr>
<tr id="id_c162dc7a-421b-45a0-8085-d88542cb4ce6">
<td align="left" valign="top">Drugs with postmarketing reports consistent with potential drug-drug interactions when coadministered with WELCHOL</td>
<td align="left" valign="top">phenytoin<sup>a</sup>, warfarin<sup>b</sup>
</td>
</tr>
<tr id="id_b76d2f9b-ed51-469c-8676-0feb10b7f359">
<td align="left" valign="top">Drugs that do not interact with colesevelam based on <content stylecode="italics">in vitro</content> or <content stylecode="italics">in vivo</content> testing </td>
<td align="left" valign="top">cephalexin, ciprofloxacin, digoxin, warfarin<sup>b</sup> fenofibrate, lovastatin, metformin, metoprolol, pioglitazone, quinidine, repaglinide, valproic acid, verapamil</td>
</tr>
</tbody>
</table>